# Study of Cardiac PET/CT Imaging to Guide Ablation Treatment of Ventricular Tachycardia

> **NCT02962076** · EARLY_PHASE1 · TERMINATED · sponsor: **Khaled Awad, MD** · enrollment: 11 (actual)

## Conditions studied

- Ventricular Tachycardia

## Interventions

- **DRUG:** [C-11] Meta-hydroxyephedrine radioactive tracer (MHED)

## Key facts

- **NCT ID:** NCT02962076
- **Lead sponsor:** Khaled Awad, MD
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-09-21
- **Primary completion:** 2023-03-01
- **Final completion:** 2024-10-31
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Investigator departing institution and enrollment not met.
- **Last updated:** 2024-12-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02962076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02962076, "Study of Cardiac PET/CT Imaging to Guide Ablation Treatment of Ventricular Tachycardia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02962076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*